Heparin, also known as unfractionated heparin (UFH), is medication which is used as an anticoagulant (blood thinner). Specifically it is used to treat and prevent deep vein thrombosis, pulmonary embolism, and arterial thromboembolism. It is also used in the treatment of heart attacks and unstable angina.[3] It is given by injection into a vein.Other uses include inside test tubes and kidney dialysis machines.Common side effects include bleeding, pain at the injection site, and low blood platelets.Serious side effects include heparin induced thrombocytopenia. Greater care is needed in those with poor kidney function.Heparin appears to be relatively safe for use during pregnancy and breastfeeding.Heparin is a naturally occurring glycosaminoglycan.
This report elaborates the market size, market characteristics, and market growth of the Sodium Heparin industry, and breaks down according to the type, application, and consumption area of Sodium Heparin. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Sodium Heparin in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Sodium Heparin market covered in Chapter 13:
Aspen Oss
Pfizer
Changshan Pharm
Hepalink
Qianhong Bio-pharma
Opocrin

In Chapter 6, on the basis of types, the Sodium Heparin market from 2015 to 2025 is primarily split into:
Heparin Sodium
Heparin Calcium
Other

In Chapter 7, on the basis of applications, the Sodium Heparin market from 2015 to 2025 covers:
UFH
LMWH

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025